---
name: "drug-discovery"
category: "bioinformatics"
version: "2.0.0"
tags: ["bioinformatics", "drug-discovery", "virtual-screening", "ADMET", "pharmacophore"]
---

# Drug Discovery

## Overview

The Drug Discovery module provides a computational toolkit for the early stages of pharmaceutical research, covering target identification, virtual screening, lead optimization, and ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling. It integrates molecular docking, pharmacophore modeling, QSAR (Quantitative Structure-Activity Relationship), molecular property calculation, and compound library management.

This module is designed for computational chemists, medicinal chemists, and bioinformaticians working on drug design projects. It supports both structure-based drug design (SBDD) using protein crystal structures and ligand-based approaches when only known active compounds are available.

## Core Capabilities

- **Molecular Property Calculation**: Lipinski's Rule of Five, TPSA, rotatable bonds, molecular weight, LogP, and drug-likeness scoring
- **Virtual Screening**: High-throughput docking using AutoDock Vina, Glide-score approximations, and pharmacophore-based filtering
- **Pharmacophore Modeling**: 3D pharmacophore generation from active compounds, feature-based screening (H-bond donor/acceptor, hydrophobic, aromatic, charge)
- **QSAR Modeling**: Machine-learning-based activity prediction from molecular fingerprints (Morgan, MACCS, topological)
- **ADMET Prediction**: Blood-brain barrier penetration, CYP450 inhibition, hERG liability, hepatotoxicity, and metabolic stability
- **Compound Library Management**: ChEMBL/PubChem API integration, SMILES/InChI parsing, RDKit molecular objects, duplicate detection by Tanimoto similarity
- **Lead Optimization**: Scaffold hopping suggestions, bioisostere replacement, and R-group enumeration
- **SAR Analysis**: Structure-Activity Relationship tables, matched molecular pair analysis

## Usage Examples

```python
from drug_discovery import (
    MoleculeProcessor,
    VirtualScreener,
    ADMETPredictor,
    CompoundLibrary,
    PharmacophoreModeler,
)

# --- Molecular Property Calculation ---
processor = MoleculeProcessor()
mol = processor.from_smiles("CC(=O)Oc1ccccc1C(=O)O")  # Aspirin
props = mol.calculate_properties()
print(f"MW: {props.molecular_weight:.1f}")
print(f"LogP: {props.logP:.2f}")
print(f"TPSA: {props.tpsa:.1f} A^2")
print(f"HBD: {props.hbd}  HBA: {props.hba}")
print(f"Drug-like (Lipinski): {props.passes_lipinski}")
print(f"QED score: {props.qed:.3f}")

# --- Virtual Screening ---
screener = VirtualScreener(
    protein_pdb="7bqc.pdb",
    grid_center=(12.5, 34.2, -8.1),
    grid_size=(20, 20, 20),
)
results = screener.dock_library(
    library="approved_drugs.sdf",
    top_n=50,
)
for hit in results[:5]:
    print(
        f"{hit.compound_id}: affinity={hit.affinity:.1f} kcal/mol, "
        f"pose_score={hit.pose_score:.2f}"
    )

# --- ADMET Profiling ---
admet = ADMETPredictor()
for hit in results[:10]:
    profile = admet.predict(hit.smiles)
    print(
        f"{hit.compound_id}: BBB={profile.bbb_penetration}, "
        f"CYP3A4={profile.cyp3a4_inhibitor}, "
        f"hERG={profile.herg_liability}, "
        f"hepato={profile.hepatotoxicity}"
    )

# --- Pharmacophore Modeling ---
modeler = PharmacophoreModeler()
pharmacophore = modeler.generate_from_actives(
    smiles_list=["CC(=O)Oc1ccccc1C(=O)O", "c1ccc(cc1)C(=O)O"],
    activity_threshold=7.0,
)
screen_hits = modeler.screen_library(
    pharmacophore=pharmacophore,
    library="chembl_compounds.smi",
    tolerance=1.5,
)

# --- Compound Library ---
library = CompoundLibrary("my_library.sdf")
library.add_from_smiles("CC(=O)Oc1ccccc1C(=O)O", name="Aspirin")
library.deduplicate(threshold=0.85)
print(f"Library size after dedup: {len(library)}")
library.export("cleaned_library.sdf")
```

## Best Practices

- Always apply drug-likeness filters (Lipinski, Veber, PAINS) before docking to reduce false positives
- Use multiple scoring functions for consensus docking to improve hit rates
- Validate ADMET predictions with experimental data when available
- Apply PAINS (Pan-Assay Interference Compounds) filtering to remove assay artifacts
- Consider multiple protein conformations (ensemble docking) for flexible targets
- Use Morgan fingerprints (radius=2, 2048 bits) for general-purpose similarity searching
- Set appropriate grid size — too small misses key interactions, too large increases noise
- Include water molecules in binding sites when they mediate key hydrogen bonds
- Report confidence intervals for QSAR predictions, not just point estimates
- For lead optimization, balance potency with ADMET properties — optimize multi-parameter

## Related Modules

- **protein-structure**: Target preparation for structure-based drug design
- **genomic-analysis**: Pharmacogenomic variant interpretation
- **sequence-alignment**: Target homology identification for template-based docking
- **phylogenetics**: Evolutionary analysis of drug target families
